TrialMedical oncology (Northwood, London, England)2013

Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.

Motohiro Tamiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.